A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

Molecular Microbiology

Volumn 19, Issue 4, 1996, Pages 791-801

  Chabalgoity, J A ^a,b   Khan, C M A ^a   Nash, A A ^c   Hormaeche, C E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; TETANUS TOXIN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BACTERIAL VACCINES; BASE SEQUENCE; FEMALE; HEAT-SHOCK PROTEINS; HERPES SIMPLEX; IMMUNOGLOBULIN ISOTYPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PERIPLASMIC PROTEINS; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; SERINE ENDOPEPTIDASES; TETANUS TOXIN; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ANIMALIA; HERPES; PINNA; SALMONELLA TYPHIMURIUM; SIMPLEXVIRUS; TYPHIMURIUM;

EID: 0030027927     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.1996.426965.x     Document Type: Article

References (49)

1. Berman, P.W., Gregory, T., Crase, D., and Lasky, L.A. (1985) Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227: 1490-1492.
2. Blacklaws, B.A., and Nash, A.A. (1990) Immunological memory to herpes simplex virus type 1 glycoprotein B and D in mice. J Gen Virol 71: 863-871.
3. Blacklaws, B.A., Krishna, S., Minson, A.C., and Nash, A.A. (1990) Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177: 727-736.
4. Bowen, J.C., Alpar, O., Philpotts, O., Roberts, I.S., and Brown, M.R.W. (1990) Preliminary studies on infection by attenuated salmonella in guinea pigs and on expression of herpes simplex virus. Res Microbiol 141: 873-877.
5. Broekhuijsen, M.P., Van Rijn, J.M.M., Blom, A.J.M., Pouwels, P.H., Enger-Valk, B.E., Brown, F., and Francis, M.J. (1987) Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both natural host and laboratory animals. J Gen Virol 68: 3137-3143.
6. Brown, A., Hormaeche, C.E., Demarco de Hormaeche, R.A., Dougan, C., Winther, M., Maskell, D., and Stocker, B.A.D. (1987) An attenuated aroA S. typhimurium vaccine elicits humoral and cellular immunity to cloned beta galactoside in mice. J Inf Dis 155: 86-92.
7. Brynestad, K., Babbitt, B., Huang, L., and Rouse, B.T. (1990) Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines. J Virol 64: 680-685.
8. Burke, R.L. (1993) Current development in herpes simplex virus vaccines. Sem Virol 4: 187-197.
9. Charles, I., and Dougan, G. (1990) Gene expression and the development of live enteric vaccines. Trends Biotechnol 8: 117-121.
10. Chatfield, S.N., Charles, I.G., Makoff, A.J., Oxer, M.D., Dougan, G., Pickard, D., Slater, D., and Fairweather, N.F. (1992a) Use of the nirB promoter to direct the stable expression of heterologous antigens in salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine. Biotechnology 10: 888-892.
11. Chatfield, S.N., Fairweather, N.F., Charles, I., Pickard, D., Levine, M., Hone, D., Posada, M., Strugnell, R.A., and Dougan, G. (1992b) Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine. Vaccine 10: 53-60.
12. Chatfield, S.N., Strahan, K., Pickard, D., Charles, I.G., Hormaeche, C.E., and Dougan, G. (1992c) Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathogen 12: 145-151.
13. Cohen, G.H., Dietzschold, B., Ponce de Leon, M., Long, D., Golub, E., Varrichio, A., Pereira, L., and Eisenberg, R.J. (1984) Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates production of neutralising antibody. J Virol 49: 102-108.
14. Coulson, N.M., Fulop, M., and Titball, R.W. (1994) Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL3261, affords protection against anthrax spore challenge. Vaccine 12: 1395-1401.
15. Cremer, K.J., Mackett, M., Wohlenberg, C., Notkins, A.L., and Moss, B. (1985) Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228: 737-740.
16. Eisenberg, R.J., Cerini, C.P., Heilman, C.J., Joseph, A.D., Dietzschold, B., Golub, E., Long, D., Poce de Leon, M., and Cohen, G.H. (1985a) Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J Virol 56: 1014-1017.
17. Eisenberg, R.J., Long, D., Ponce de Leon, M., Matthews, J.T., Spear, P.G., Gibson, M.G., Lasky, L.A., Berman, P., Golub, E., and Cohen, G. (1985b) Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol 53: 634-644.
18. Everest, P., Frankel, G., Li, J., Lund, P., Chatfield, S., and Dougan, G. (1995) Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: Influence of growth in mammalian cells. FEMS Micro Letts 126: 97-101.
19. Greenspan, N.S., and Cooper, L.J.N. (1992) Intermolecular cooperativity: a clue to why mice have IgGS. Immunol Today 13: 164-168.
20. Heber-Katz, E., Hollosi, M., Dietzschold, B., Hudecz, F., and Fasman, G.D. (1985) The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation. J Immunol 135: 1385-1390.
21. Heber-Katz, E., Valentine, S., Dietzschold, B., and Burns-Purzycki, C. (1988) Overlapping T cell antigenic sites on a synthetic peptide fragment from herpes simplex virus glycoprotein D, the degenerate MHC restriction elicited, and functional evidence for antigen-la interaction. J Exp Med 167: 275-287.
22. Ho, R.J., Burke, R.L., and Merigan T.C. (1989) Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs. J Virol 63: 2951-2958.
23. Hoiseth, S.K., and Stocker, B.A.D. (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238-239.
24. Hormaeche, C.E., Khan, C.M.A., Mastroeni, P., Villareal, B., Dougan, G., and Chatfield, S.N. (1995) Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In Molecular and Clinical Aspects of Vaccine Development. Ala'Aldeen, D., and Hormaeche, C.E. (eds). England: John Wiley and Sons Ltd., pp. 119-153.
25. Johnson, K.S., Charles, I.G., Dougan, G., Miller, I.A., Pickard, D., O'Goara, P., Costa, G., Ali, T., and Hormaeche, C.E. (1991) The role of a stress-response protein in bacterial virulence. Mol Microbiol 5: 401-407.
26. Khan, C.M.A., Villareal-Ramos, B., Pierce, R.J., Hormaeche, R.D., McNeill, H., Ali, T., Fairweather, N., Chatfield, S., Capron, A., Dougan, G., and Hormaeche, C.E. (1994a) Construction, expression and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide comprising amino acids 115-131 of the P28 glutathione S-transferase, expressed as C-terminal fusions to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. J Immunol 153: 5634-5642.
27. Khan, C.M.A., Villareal-Ramos, B., Pierce, R.J., Riveau, G., Hormaeche, R.D., McNeill, H., Ali, T., Fairweather, N., Chatfield, S., Capron, A., Dougan, G., and Hormaeche, C.E. (1994b) Construction, expression and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella. Proc Natl Acad Sci USA 91: 11261-11265.
28. Martin, S., Moss, B., Berman, P.W., Laskey, L.A., and Rouse, B.T. (1985) Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. J Virol 61: 726-734.
29. Maskell, D.J., Sweeney, K.J., O'Callaghan, D., Hormaeche, C.E., Liew, F.Y., and Dougan, G. (1987) Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Path 2: 211-221.
30. Meignier, B., Jourdier, T.M., Norrild, B., Pereira, L., and Roizman, B. (1987) Immunisation of experimental animals with reconstituted glycoprotein mixtures of herpes simpex virus 1 and 2: protection against challenge with virulent virus. J Inf Dis 155: 921-930.
31. Miller, I.A., Chatfield, S., Dougan, G., Desilva, L., Joysey, H.S., and Hormaeche, C.E. (1989) Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: Use in identifying a role for aroD in attenuating virulent Salmonella strains. Mol Gen Genet 215: 312-316.
32. Minson, A.C., Hodgman, T.C., Digard, P., Hancock, D.C., Bell, S.E., and Buckmaster, E.A. (1986) An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralisation. J Gen Virol 67: 1001-1013.
33. Mishkin, E.M., Fahey, J.R., Kino, Y., Klein, R.J., Abramovitz, A.S., and Mento, S.J. (1991) Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models. Vaccine 9: 147-153.
34. Mosier, D.E., and Subbaro, B. (1982) Thymus-independent antigens: complexity of B lymphocyte activation revealed. Immunol Today 3: 217-222.
35. Nash, A.A., and Cambouropoulos, P. (1993) The immune response to herpes simplex virus. Sem Virol 4: 181-186.
36. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol 68: 825-833.
37. Rooney, J.F., Wohlenberg, C., Cremer, K.J., Moss, B., and Notkins, L.A. (1988) Immunisation with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination. J Virol. 62: 1530-1534.
38. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual. 2nd Edn. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
39. Stanberry, L.R. (1992) Pathogenesis of Herpes Simplex Virus infection and animal models for its study. In Current Topics in Microbiology and Immunobiology. Vol. 179, Herpes Simplex Virus. Pathogenesis, Immunobiology and Control. Rouse, B.T. (ed.). Berlin: Springer Verlag, pp. 15-30.
40. Stanberry, L.R., Burke, R.L., and Myers, M.G. (1987) Herpes Simplex Virus glycoprotein treatment of recurrent genital herpes. J Infect Dis 157: 156-163.
41. Strahan, K. (1992) Expression of SIV antigens in live salmonella vaccines. PhD Thesis, University of Cambridge, Cambridge, UK.
42. Straus, S.E., Savarese, B., Tigges, M., Freifeld, A.G., Krause, P.R., Margolis, D.M., Meier, J.L., Paar, D.P., Adair, S.F., Dina, D., Dekker, C., and Burke, R.L. (1993) Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J Inf Dis 167: 1045-1052.
43. Tite, J.P., Gao, X.M., Hughes-Jenkins, C.M., Lipscombe, M., O'Callaghan, D., Dougan, D., and Liew, F.Y. (1990) Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier. Immunology 70: 540-546.
44. Van der Ploeg, J.R., Drijfhout, J.W., Feiglbrief, M., Bloemhoff, W., Welling, G.W., and Welling-Wester, S. (1989) Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein D. J Immunol Methods 124: 211-217.
45. Watari, E., Dietzschold, B., Szokan, G., and Heber-Katz, E. (1987) A synthetic peptide induces long-term protection from lethal infection with Herpes Simplex Virus 2. J Exp Med 165: 459-470.
46. Whitley, R.J. (1990) Herpex Simplex Viruses. In: Virology. 2nd Edn. Fields, B.N., and Knipe, D.M. (eds). New York: Raven Press Ltd., pp. 1843-1887.
47. Whitley, R.J., Goldsmith, S., and Gnann, J. (1990) Herpes viruses in the immunocompromised host. In: Control of Virus Diseases. SGM Symposium 45. Dimmock, N.J., Griffiths, P.D., and Madeley, C.R. (eds). Cambridge, UK: Cambridge University Press, pp. 315-319.
48. Wyckoff III, J.H., Osmand, A.P., Eisenberg, R.J., Cohen, G.H., and Rouse, B.T. (1988) Functional T cell recognition of synthetic peptides corresponding to continuous antibody epitopes of herpes simplex virus type 1 glycoprotein D. Immunobiology 177: 134-148.
49. Zheng, B., Graham, F.L., Johnson, D.C., Hanke, T., McDermott, M.R., and Prevec, L. (1993) Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors. Vaccine 11: 1191-1198.